| Peramivir |
| (1S,2S,3R,4R)-3-[(1S)-1-(Acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxycyclopentanecarboxylic acid |
| (CAS 330600-85-6;229614-55-5) |
 |
| Description： |
Peramivir (RWJ 270201; Rapiacta; BCX 1812) is a transition-state analogue and a potent, specific influenza viral neuraminidase inhibitor with an IC50 of median 0.09 nM.
IC50 Value: 0.09 nM
Target: Neuraminidase
Peramivir is an experimental antiviral drug developed by BioCryst Pharmaceuticals for the treatment of influenza. It has been authorized for the emergency use of treatment of certain hospitalized patients with known or suspected 2009 H1N1 influenza. Peramivir is a neuraminidase inhibitor, acting as a transition-state analogue inhibitor of influenza neuraminidase and thereby preventing new viruses from emerging from infected cells. From Wikipedia |
| Product No. |
KT20091 |
| Product Name |
Peramivir |
| Synonyms |
RWJ 270201; Rapiacta; BCX 1812; RWJ-270201; RWJ270201; BCX-1812; BCX1812 |
| Formal Name |
(1S,2S,3R,4R)-3-[(1S)-1-(Acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxycyclopentanecarboxylic acid |
| CAS Number |
330600-85-6;229614-55-5 |
| Molecular Formula |
C15H28N4O4 |
| Formula Weight |
328.41 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
Crizotinib
PTC-209
AZ191
CX-4945
Tacrolimus
Verteporfin
Bendamustin HCl
Cyclosporin A
Cabazitaxel
|
|
